Nitric oxide could promote development of Barrett's esophagus by S-nitrosylation-induced inhibition of Rho-ROCK signaling in esophageal fibroblasts

Am J Physiol Gastrointest Liver Physiol. 2022 Jan 1;322(1):G107-G116. doi: 10.1152/ajpgi.00124.2021. Epub 2021 Nov 17.

Abstract

Barrett's esophagus arises in the process of wound healing in distal esophageal epithelium damaged by gastroesophageal reflux disease. Differentiation of fibroblast into myofibroblasts, a smooth muscle cell-like phenotype and tissue contraction are crucial processes in wound healing. No study has evaluated mechanism by which luminal esophageal nitric oxide (NO) affect Rho-associated coiled coil-forming protein kinase (Rho-ROCK) signaling pathway, a key factor of tissue contraction, in stromal fibroblasts to develop Barrett's esophagus. Using esophageal fibroblasts, we performed collagen-based cell contraction assays and evaluated influence of Rho-ROCK signaling in the exposure to acidic bile salts and NOC-9, which is an NO donor. We found that enhanced cell contraction induced by acidic bile salts was inhibited by NO, accompanied by decrease in phosphorylated myosin light chain expression and stress fiber formation. NO directly S-nitrosylated GTP-RhoA and consequently blocked Rho-ROCK signaling. Moreover, exposure to NO and Y27632, a Rho-ROCK signaling inhibitor, decreased α-SMA expression and increased bone morphogenetic protein-4 (BMP4) expression and secretion. These findings could account for the increased expression of BMP4 in the columnar epithelial cells and stromal fibroblasts in human Barrett's esophagus. NO could impair wound contraction by blocking the Rho-ROCK signaling pathway and promote the development of Barrett's esophagus.NEW & NOTEWORTHY Barrett's esophagus is the condition where esophageal epithelium damaged by gastroesophageal reflux disease (GERD) is abnormally healed via replacing of metaplastic columnar epithelium, but very few studies have conducted focusing wound healing in the development of Barrett's esophagus. Esophageal luminal nitric oxide inhibits Rho-ROCK signaling pathway in esophageal fibroblasts, which leads to delay tissue contraction, a pivotal step in proper wound healing. Moreover, this inhibition increases tissue BMP4 expression. Impaired wound healing could be related to Barrett's esophagus.

Keywords: Barrett’s esophagus; Rho-ROCK signaling; S-nitrosylation; nitric oxide; tissue contraction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amides / pharmacology
  • Barrett Esophagus / drug therapy
  • Barrett Esophagus / metabolism*
  • Cell Differentiation / drug effects
  • Epithelial Cells / metabolism
  • Esophageal Neoplasms / metabolism
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Gastroesophageal Reflux / metabolism*
  • Humans
  • Metaplasia / drug therapy
  • Metaplasia / metabolism*
  • Nitric Oxide / metabolism*
  • Pyridines / pharmacology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Amides
  • Pyridines
  • Y 27632
  • Nitric Oxide

Associated data

  • figshare/10.6084/m9.figshare.14306909.v1